Introduction
Originally described by Theodore Leber in 1869, Leber congenital amaurosis (LCA, MIM 204000) is an autosomal recessive condition distinct from other retinal dystrophies and responsible for congenital blindness. 1 The diagnosis is usually made at birth or during the first months of life in an infant with total blindness or greatly impaired vision, normal fundus and non recordable electroretinogram (ERG,
). It is usually accepted that LCA accounts for 5% of all retinal dystrophies. 3 LCA is a genetically heterogeneous condition, and four disease genes have been hitherto identified: GUCY2D (retGC-1), 4 RPE65, 5, 6 CRX 7 ± 9 and AIPL1 of our series. Two additional loci have been reported, namely LCA3 and LCA5 on chromosomes 14q24 and 6q11-q16, respectively. 11, 12 In an effort to identify novel LCA loci, we have undertaken a genome-wide search for homozygosity in seven consanguineous and multiplex families with no mutation in known LCA genes, and unlinked to LCA3 or LCA5. We found evidence of homozygosity at the D14S283 and D14S275 loci on chromosome 14q11 in two out of seven families. Interestingly, the gene encoding the`retinitis pigmentosa GTPase regulator interacting protein' (RPGRIP1) was found to map to the 14q11 chromosomal region. 13, 14 Here, we report the characterization of the complete exonintron structure of the RPGRIP1 gene and the identification of mutations in two families consistent with linkage to chromosome 14q11 as well as in six out of 86 unrelated patients. Taken together, our results show that RPGRIP1 accounts for eight out of 142 LCA families (5.6%), while the other four reported genes account for 49 out of 142 LCA families (34.5%).
Patients and methods

Patients
In addition to the seven consanguineous and multiplex families selected for the genome-wide search for homozygosity, 86 families were studied of which 14 were multiplex, 11 were consanguineous, and five were consanguineous and multiplex. All patients fulfilled the minimal criteria for diagnosis of LCA described elsewhere. 19, 20 Genome-wide search for homozygosity A genome-wide search for homozygosity was undertaken independently in all patients of the seven LCA families (n=17) using the 382 pairs of fluorescent oligonucleotides of the Genescan Linkage Mapping Set, Version II (Perkin Elmer Cetus) under conditions recommended by the manufacturer. Amplified fragments were electrophoresed and analysed on an automatic sequencer (ABI 377). The polymorphic markers have an average spacing of 10 cM throughout the genome.
Mutation screening of NRL in the two families linked to 14q11
The three exons (two coding exons) of the NRL gene were amplified and sequenced using specific primers designed from the intronic sequences nearby the intron-exon junctions (data not shown, available on request).
Characterization of the complete exon-intron structure of the human RPGRIP1 gene Human retinal total RNA (4.5 mg) was heated for 10 min at 658C, in a buffer (19 ml) containing 1 mM dithiotreitol, 5 mM MgCl 2 , 1 mM dNTP, 2.5 mM random hexamers, 16 buffer II, 1 unit RNase Inhibitor (GeneAmp RNA PCR Kit, Applied Biosystems, Foster City, USA). After ice quenching (5 min), the RNAs were reverse transcribed by adding 2.5 units of MuLV Reverse Transcriptase (GeneAmp RNA PCR Kit, Applied Biosystems, Foster City, USA) for 1.5 h at 428C.
Reverse transcribed mRNAs (1 ml) were subsequently submitted to successive PCR amplifications using specific forward primers designed from exons-4, -3, -2, -1 and 1 of the C14000056 clone and a unique reverse primer located in exon 10 of the RPGRIP1 gene (Figure 2 ). Reactions were carried out in a buffer (20 ml) containing 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 1.5 mM MgCl, 200 mM of each dNTP, 0.5 mM of each primer and 0.75 U of Taq DNA polymerase (Life Technologies). After an initial denaturation for 5 min at 968C, denaturation was at 968C for 20 s, annealing was for each combination of primers at 608C for 15 s and extension was at 728C for 30 s, for 34 cycles followed by a final extension, for 7 min at 728C. The 1 kb fragment amplified between primers PF1/PR was loaded onto a 1% low melting agarose gel and purified by phenol-chloroform extraction and recovered by ethanol precipitation. The purified fragment was directly sequenced using the Big Dye Terminator Cycle Sequencing Kit (ABI Prism).
The genomic structure of the RPGRIP1 gene was determined by comparing the PF1/PR 1 kb sequence with the genomic sequence of the C14000056 clone.
Mutation screening of the RPGRIP1 in the two families linked to 14q11 The 24 exons encoding RPGRIP1 were amplified using specific primers designed from the intronic sequences nearby the intron-exon junctions ( Table 1 ). The PCR and sequencing conditions are similar to that described above except for annealing temperature which was at 568C for each exon.
Segregation analysis of the G2237A mutation The G2237A mutation created a Taq1 restriction site. Exon 15 of the RPGRIP1 gene was amplified as described in the previous section. PCR products were digested for 1 h at 658C using restriction enzyme Taq1 (5 u) in the buffer supplied by the manufacturer (Life Technologies). Digested fragments were electrophoresed on a 3% agarose low melting and 1% agarose gel.
Screening of a large series of LCA patients The search for mutations was carried out by single strand conformation polymorphism (SSCP) analysis and/or denaturing high-pressure liquid chromatography (DHPLC).
For SSCP analysis, genomic DNA (200 ng) was submitted to PCR amplification using 0.5 mM of specific primers (Table 1) and alpha 33 P dCTP (0.07 ml, 10 mCi/ml NEN For DHPLC analysis, heteroduplex formation was induced by heat denaturation of PCR products at 948C for 10 min, followed by gradual reannealing from 948C to 258C over 30 min. DHPLC analysis was performed with the WAVE DNA fragment analysis system (Transgenomic). PCR products were eluted at a flow rate of 0.9 ml/min with a linear acetonitrile gradient. The values of the buffer gradients (buffer A, 0.1 M triethylammoniumacetate; buffer B, 0.1 M triethylammoniumacetate/25% acetonitrile), start and end points of the gradient, and melting temperature predictions were determined by the WAVEMAKER software (Transgenomic). Analysis per sample took 7.5 min, including regeneration and re-equilibration to the starting conditions. Optimal run temperatures were empirically determined. Mobile-phase temperatures were assessed within a 58C window above and below the suggested run temperature on the basis of each fragment's characteristic melting profile.
PCR fragments displaying SSCP and/or DHPLC abnormal profiles were further sequenced as described above.
Results
Genome-wide search for homozygosity
The 382 polymorphic markers of the Genescan Linkage Mapping Set Version II were tested in seven consanguineous families. For each of the seven families, evidence of homozygosity was found for several independent loci on various chromosomes. Subsequently, polymorphic markers flanking the various homozygote loci were studied in the corresponding families. These analyses allowed to exclude several chromosomal regions since (i) homozygosity for the marker only reflected a lack of informativity in the parents, and surrounding markers were heterozygotes in the patients, or (ii) the parents were indeed informative for a given marker but flanking markers in the immediate vicinity (Y*0%) were heterozygotes in the patients (data not shown, available on request). Conversely, we found evidence for homozygosity at the D14S283 and D14S275 loci in all patients of two unrelated families (SED and NIL families, Figure 1 ). Homozygosity for this chromosomal region was confirmed by flanking markers and the shortest area of homozygosity was defined by the D14S261 and D14S257 interval ( Figure 1 ). This hint of mapping led us to search for candidate genes in this chromosomal region. Interestingly, two genes highly expressed in the retina were found to map to in this genetic interval.
Screening of the neural retina-specific leucine zipper (NRL) gene A search for mutations in the neural retina-specific leucine zipper gene 15 was undertaken in the homozygote patients of the two consanguineous families linked to this region (Families SED and NIL; Figure 1 ). Direct sequencing of the three exons of the NRL gene revealed no deleterious change in any of the patients, supporting the exclusion of this gene in the two families. Characterization of the complete exon-intron structure of the human RPGRIP1gene Two groups have recently reported the identification of a full length human RPGRIP1 cDNA encoding a 902 amino acid protein. 13, 14 Sequence alignment of this predicted protein with the RPGRIP1 orthologues showed that the mouse and bovine counterparts were extending forward the N-terminal region (Entrez Protein Sequence Search accession numbers AAG10247, NP_076368, respectively). Subsequently, we tried to determine whether the human gene streched upstream the 5' end of this cDNA sequence, especially as several alternative transcripts were described. 13, 14, 18 A search in the Human Genome Project Working Draft at USC using the Draft Genome Browser v4 allowed the identification of a 58 kb sequence (C14000056, nt17331166 ± 17389186; Figure 2A ), 5 kb upstream the 5' end of the originally described RPGRIP1 gene (referred to as RPGRIP1 partial, nt17394268 ± 17427972; Figure 2A ). This clone was predicted to contain 13 exons (Fgenesh++ Gene Predictions; Figure 2A ). The cDNA sequence including exons 1 ± 9 contained an open reading frame (ORF, start: nt17364655) encoding a 384 amino acid sequence highly similar to the N-terminal part of the murine RPGRIP1 protein.
No PCR amplifications of reverse transcribed human retinal RNA were obtained when using primers PF-4/PR, PF-3/PR, PF-2/PR, PF-1/PR, giving support to the view that predicted exons-4 to -1 of the C14000056 sequence did not belong to the RPGRIP1 gene (Figure 2A ). Conversely, a 1321 bp fragment was amplified using primers PF 1/PR (Figure 2A ). Direct sequencing of the PF 1/PR fragment supported the location of the translation initiation codon at position nt17364655 (referred to as nt1 in Figure 3 ) and showed that (i) the predicted intron 8/exon 9 boundary of the C14000056 clone was to be shifted 6 bp in the 5' direction, (ii) the four bases at the 3' end of the C14000056 were intronic and (iii) the 5 kb sequence between the original RPGRIP1 and C14000056 sequences corresponded to an intron (Figure 2A ). In total, the RPGRIP1 gene consists in 24 exons and 23 introns (Figure 3) . The predicted product would yield a protein product of 1287 amino acids (Figure 3) . Specific primers were designed from the intronic sequences in order to screen the 24 coding exons in all patients of our series ( Table 1) .
Identification of RPGRIP1 mutations in LCA patients
Very recently, analysis of radiation hybrids have resulted in the assigment of the RPGRIP1 gene to chromosome 14q11, at the D14S932 locus. 13, 14 Therefore, this gene was regarded as an attractive candidate gene by virtue of both position and function. A search for mutations was undertaken in Figure 1 Pedigree of the seven consanguineous and multiplex families ascertained for the genome-wide search for homozygosity and haplotypes of two of them consistent with linkage to the 14q11 region. Regions of homozygosity are squared.
RPGRIP1, the fifth LCA-causing gene S Gerber et al 564 homozygote patients of the two families consistent with linkage to 14q11 by direct sequencing of the 15 coding exons originally reported 13, 14 as well as the nine additional exons reported here. The two patients of the first family of Moroccan origin were found to carry a homozygous missense mutation in exon 15 at nucleotide 2237 (G2237A; Family SED, Figure 4A ). This mutation changed a glycine (non polar, uncharged amino acid) into a glutamic acid (charged amino acid) in the protein (G746E). The glycine at position 746 is present in both human 1a and 1b RPGRIP1 isoforms. 13, 14 In addition, it is a highly conserved amino acid, which lies in a very conserved region in both bovine and murine sequences. This base change created a restriction site for the Taq1 enzyme. Restriction analysis of the entire family showed that the mutation segregated with the disease ( Figure 4A ) and was absent in 252 normal chromosomes. In the second family (Family NIL, Figure 1 ), we found a homozygous deletion of nt 511 in exon 4 leading to a premature stop codon, 19 amino acids downstream, in both affected children ( Figure 4B ). This deletion was found to be inherited from both carrier parents and was not identified in any of the 252 normal chromosomes studied. Subsequently, we undertook a search for mutations in a large panel of 86 LCA patients unrelated to any of the four already identified LCA genes and found RPGRIP1 gene mutations in six additional families. In one family of compound origin (French, English, German and Bulgarian), the affected child was found to harbour a heterozygote 2 bp insertion (2566+2 insTT) in exon 16, leading to a premature stop codon, three amino acids downstream (Family LOB, Figure 5 ). The second mutation was found to be a heterozygote insertion of a guanine in exon 23, at position 3629 (ins 3629+1G; Figure 5 ). This latter mutation resulted in a frameshift and the apparition of a stop codon, five amino acids downstream. The segregation of the two mutations in the family revealed that the 2566+2TT and 3629+1G insertions were inherited from the carrier mother and father, respectively (Family LOB, Figure 5 ). In addition, these two mutations resulted into an abnormal DHPLC profile allowing to demonstrate their absence in 252 normal chromosomes.
In another family of Belgian origin, the affected child was found to be a compound heterozygote as well. The first mutation, a C ± T transition at nucleotide 2668 (exon 16) a RPGRIP1, the fifth LCA-causing gene S Gerber et al 566 resulted in the substitution of an arginine into a stop codon (R890X). This non-sense mutation is expected to truncate more than half of the protein. The second mutation was a missense mutation in exon 21 at nucleotide 3341 (A3341G, Family NES; Figure 5 ). This latter mutation changed an aspartic acid (charged amino acid) into a glycine (non polar, uncharged amino acid) in the protein (D1114G). The aspartic acid at position 1114 is present in all known isoforms of the protein and is highly conserved in bovine and murine sequences. In addition, this amino acid lies in the highly conserved and predicted globular Cterminal region corresponding to the cognate RPGRinteracting domain (RID). Each mutation in this patient was inherited from a healthy parent and was absent in 252 normal chromosomes. Interestingly, a patient born to consanguineous parents of Moroccan origin was homozygous for the same missense mutation (D1114G, Family MOU, Figure 5) .
In a family of French origin, the affected child was found to carry a heterozygote C ± T transition (C1525T) in exon 12 resulting in the substitution of a glutamine for a stop codon (Q509X, Family GRA, Figure 5 ). The mutation was found to be inherited from the healthy father. In an other French family, the LCA patient was found to carry a heterozygote 4 bp insertion in exon 12 (1501+4 insTGTC; Family HER, Figure 5 ), leading to a frameshift and a premature stop codon, eight amino acids downstream. This mutation was inherited from his healthy mother. In both families, the RPGRIP1 mutation identified was not found in any of the 252 normal chromosomes studied.
Finally, in a family of French origin, two first cousins were affected with LCA. One of them (III2) was found to carry a heterozygote 3 bp in frame deletion in exon 24 (del nt 3835 ± 3837; Family GUY, Figure 5 ). The mutation led to the deletion of the glutamic acid located eight amino acids upstream to the stop codon (del E1279). This amino acid, found in both RPGRIP1 a and b isoforms, is conserved in bovine and murine sequences and lies in the highly conserved RID domain. The E1279 deletion identified in patient III2 was inherited from his healthy father (II1) and was therefore absent in his affected cousin (III4, Figure 5 ). Both mutations identified in this family resulted in an abnormal DHPLC profile that was not found in any of the 252 normal chromosomes studied. For the last three families, b Figure 3 cDNA and predicted amino acid sequence of the human RPGRIP1 gene. The translation initiation codon is double underlined while the translation initiation codon reported by Roepman et al 13 and Boylan and Wright 14 is underlined. Intron-exon boundaries are shown.
the second mutation, searched by direct sequencing, remains unidentified.
Discussion
LCA is a relatively common disease with a high rate of consanguinity. We have long assumed that this condition could be accounted for by mutations in various genes. Indeed, six LCA genes have been hitherto mapped namely, LCA1 and LCA4 on chromosome 17p13.1, ). LCA3 and LCA5 respectively account for the disease in a consanguineous Saudi Arabian LCA family and a multigenerational kindred of Old Order River Brethren, a religious isolate descended from Swiss immigrants to America in the 1750s. All together, the four identified genes accounted for only one third of the LCA cases in our series.
We have found homozygosity for polymorphic markers located on chromosome 14q11 in two unrelated consanguineous families. Two known candidate genes were reported to map to this chromosomal region. One of them, NRL, was excluded in both families. In the RPGRIP1 gene, we found a homozygous missense mutation in one of the two families (Family SED) but direct sequencing of the 15 known exons (13 ± 14) failed to detect any mutation in the second family (Family NIL). To determine whether the missense mutation identified in family SED involved a conserved amino acid, we aligned the bovine, murine and human sequences. This analysis revealed that this amino acid was conserved in all three species, and that the murine and bovine proteins were longer than the human one in the N-terminal region. This last finding along with the lack of detection of mutation in the NIL family prompted us to search for additional exons in the 5' region of the originally reported RPGRIP1 sequence (13 ± 14) . This study allowed the identification of nine additional coding exons, one of which was found to be homozygously mutated in the NIL family. Further screening of the 24 RPGRIP1 exons in 86 additional LCA patients allowed the identification of mutations in six of them.
In total, we report here the identification of mutations in a novel LCA causing gene, in eight unrelated families unlinked to any of the four already identified genes. Among the nine mutations identified, eight were different (five truncating mutations, one in frame deletion of 3 bp and two missense mutations). Three of the eight patients, born to consanguineous parents, harboured homozygous mutations, two out of eight were compound heterozygotes of which one harboured a truncating mutation on each allele of the gene and in three out of eight individuals one single mutation was detected Figure 5 Identification and segregation of the RPGRIP1 mutations in LCA families. C=control; P=patient; +=wild type allele.
(two truncating mutations and one in frame deletion of 3 bp), and the direct sequencing of all RPGRIP1 exons and intron-exon boundaries failed to detect the second mutation.
Among the 142 unrelated LCA patients of our series, 49 were found to harbour mutations in one of the four already reported genes (34.5%) and eight in the RPGRIP1 gene (5.6%). Among the eight different mutations identified in this last gene, five out of eight are expected to result in the truncation of the protein. Although it was unlikely that these mutations were not disease-causing, we have studied 126 normal controls by DHPLC and evidenced that, conversely to the LCA patients harbouring these truncating mutations, the normal controls did not display abnormal DHPLC profiles. The three others (two missense mutations and one in frame 3 bp deletion) concern highly conserved amino acids in bovine and murine sequences and lie in highly conserved regions (two in the RPGR-interacting domain). Hence, the identification of null mutations and of mutations that involve highly conserved amino acids suggest that the interaction of RPGRIP1 with RPGR is severely altered in the retina of patients with LCA.
RPGRIP1 is a novel protein that has been shown to specifically interact with RPGR in bovine, mouse and human. 13, 14, 18 Several alternatively spliced transcripts have been identified in the three species. Some transcripts have a retina-restricted expression and interact specifically with RPGR in vivo and in vitro. 13 Sequence analyses of all isoforms revealed the presence of a highly conserved and predicted globular C-terminal region corresponding to the cognate RPGR-interacting domain (RID) and two coiled-coil domains at the N terminus. 13 Database analyses of the translated products revealed that the coiled-coil domains have significant homology to counterpart domains of proteins involved in membrane and vesicular trafficking. 13 Interestingly, it has been shown that, in mouse, RPGRIP1 co-localised with RPGR in the connecting cilia of both rod and cone photoreceptors. It has been proposed that RPGRIP1 serves as a scaffold to anchor regulatory complexes including RPGR within the connecting cilium. In addition, RPGRIP1 might be an essential factor so that RPGR can normally play its putative role in maintaining the polarised protein distribution across the connecting cilium by facilitating directional transport or restricting redistribution. 18 In conclusion, we report here the identification of a fifth LCA gene involved in a physiological pathway different from the previously reported ones and resulting from a novel mechanism. Hopefully, the identification of the exact role of RPGRIP1 in photoreceptor will improve our understanding of this complex retinal pathology.
While this work was in the reviewing stage, Dryja et al 21 reported similar findings. Indeed, the study of the 24 RPGRIP1 coding exons allowed the identification of mutations in four out of 57 LCA families. Among them, three harboured two null RPGRIP1 alleles and one was compound heterozygote for missense mutations.
Taken together, these two independent studies strongly support the involvement of the RPGRIP1 gene in about 6 ± 7% of LCA cases.
